mRNA |
sitagliptin |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.8 |
mRNA |
Sorafenib |
CCLE |
pan-cancer |
AAC |
-0.012 |
0.8 |
mRNA |
PD-0332991 |
CCLE |
pan-cancer |
AAC |
-0.012 |
0.8 |
mRNA |
Sunitinib |
FIMM |
pan-cancer |
AAC |
0.044 |
0.8 |
mRNA |
MI-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.0097 |
0.8 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0089 |
0.8 |
mRNA |
HLI 373 |
CTRPv2 |
pan-cancer |
AAC |
0.0087 |
0.8 |
mRNA |
CGP-082996 |
GDSC1000 |
pan-cancer |
AAC |
0.013 |
0.8 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0081 |
0.8 |
mRNA |
BRD-M00053801 |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |